RT Journal Article
SR Electronic
T1 Correction: <em>Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial</em>
JF RMD Open
JO RMD Open
FD EULAR
SP e000723corr1
DO 10.1136/rmdopen-2018-000723corr1
VO 4
IS 2
YR 2018
UL http://rmdopen.bmj.com/content/4/2/e000723corr1.abstract
AB